Report Highlights
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Report Includes
- 27 data tables and 35 additional tables
- An analysis of the global markets for commercial amino acids
- Characteristics of the 20 essential commercial amino acids encoded in the genetic code, their current and future applications, associated technologies, and leading manufacturers
- Analyses of global market trends, with historic market revenue data from 2021 to 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application and region
- A look at the market dynamics, technological advances, regulations, and the influence of macroeconomic factors
- A Porter’s Five Forces analysis and a global supply chain analysis
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- A review of recent patents and R&D activity related to bio-based commercial amino acids
- Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding
- Profiles of market leaders, including Ajinomoto Co. Inc., Evonik Industries AG, DSM, ADM and CJ Corp.
Report Scope
This report on the global commercial amino acids market thoroughly analyzes the current state of the market, including market size, growth trends, and segmentation by product type and application. It explores critical drivers, challenges and opportunities that will affect the use of commercial amino acids. The report focuses on primary applications, namely animal feed, food flavoring and specialized uses. The report also provides insights into the competitive landscape by profiling major industry players and their strategic moves. Regional analyses highlight differences in market dynamics across North America, Europe, Asia-Pacific, LATAM, and Rest of the World (RoW). Additionally, the report identifies emerging trends and offers forecasts for future market developments.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2023 | ||||||||||||
Forecast period considered | 2024-2029 | ||||||||||||
Base year market size | $30.1 Billion | ||||||||||||
Market size forecast | $42.8 Billion | ||||||||||||
Growth rate | CAGR of 6.1% from 2024 to 2029 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | By Product Type, Application, and Region | ||||||||||||
Regions covered | North America, Europe, Asia-Pacific, LATAM, and Rest of the World (RoW) | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global amino acids market was $28.6 billion in 2022 and it should reach $38.8 billion by 2028 from $30.1 billion in 2023 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2023 to 2028.
Report Highlights
The U.S. amino acid market was valued at around $1.9 billion in 2016. This market will grow from nearly $2.0 billion in 2017 to $2.5 billion by 2022 with a compound annual growth rate (CAGR) of 4.8% for the period of 2017-2022.
Report Highlights
The U.S amino acids market reached $1.5 billion in 2012. This market is expected to grow to nearly $1.6 billion in 2013 and nearly $2 billion in 2018, a compound annual growth rate (CAGR) of 4.5%.
Report Highlights
The U.S. market for amino acids represents 20% of the global market with nearly $1.6 billion (in 2011), and is likely to exceed $1.8 billion by 2016, a compound annual growth rate (CAGR) of 2.8% between 2011 and 2016.
Report Highlights
- The global market for protein drugs is expected to increase from an estimated $1.1 billion in 2008 to $1.3 billion in 2013, a compound annual growth rate (CAGR) of 2.9%.
- Amino acids used as flavorants generated an estimated $510.4 million in 2008. This segment should reach $588.2 million in 2013, for a CAGR of 2.9%.
- The animal feeds segment was worth $472.4 million in 2008. This is expected to reach $526.4 million in 2013, for a CAGR of 2.2%.
Report Highlights
-
The U.S. amino acid market will likely surpass $1.5 billion by 2005. Annual growth should be 3.3% on average per year (AAGR) while individual amino acids could see growth spurts.
-
With anticipated 2005 U.S. annual sales exceeding $900 million, the animal feed supplements market will remain the largest market category for amino acids.
-
The four amino acids used as food flavoring agents will account for more than $450 million in 2005.
-
Sales of specialty amino acids used for feeding solutions, pharmaceuticals, biotechnology and medical applications, are expected to rise at an AAGR of 6.5% to about $150 million in 2005.
Report Highlights
-
Twenty amino acids go into making up the commercial amino acid market. This group plays many roles in a variety of fields including foods, animal feeds, cosmetics, medicines, and biotechnology as well as some industrial applications. In dollar terms, the most important current uses are in the animal feed industries and human food uses.
-
The three primary categories of commercial amino acids in the U.S. represented a billion-dollar market for the first time in 1999. The U.S. amino acid market should again surpass the billion-dollar mark in 2000 as factories across the nation and around the world increase production and sales to meet a growing demand. The U.S. amino acid market will likely surpass $1.5 billion by 2005.
-
With anticipated 2000 U.S. annual sales exceeding $800 million, the animal feed supplements market represents the largest market category for amino acids. Export sales of amino acid animal feed supplements will exceed $250 million.
Related Reports
Global Markets for Chemicals for Cosmetics & Toiletries
The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.
Nutraceuticals: Global Markets
The global market for nutraceuticals is expected to grow from $418.2 billion in 2024 and is projected to reach $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.
Global Markets for Animal Therapeutics and Diagnostics
The global market for animal therapeutics and diagnostics is estimated to increase from $61.0 billion in 2023 to reach $81.2 billion by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.
Global Markets for Bioengineered Protein Drugs
The global market for bioengineered protein drugs is estimated to increase from $354.1 billion in 2022 to reach $521.3 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Recent Reports
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.
Biomarkers: Technologies and Global Markets
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Top Trending Reports
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.
Biomarkers: Technologies and Global Markets
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
In Vitro Diagnostics: Technologies and Global Markets
The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
OTC Drugs, Medical Devices and Diagnostics: Global Markets
The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More